— Know what they know.
Not Investment Advice

POM NASDAQ

POMDOCTOR Ltd
1W: -17.3% 1M: -7.0% 3M: -40.7% YTD: +163.9%
$0.86
-0.06 (-6.52%)
 
Weekly Expected Move ±17.0%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 62 · $5.8M mcap · 157230 float · 43.43% daily turnover · Short 46% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$343M +12.4% ▲
3Y CAGR: +16.7%
Gross Profit
$48M +23.2% ▲
3Y CAGR: -3.2%
Operating Income
-$26M -15.9% ▼
Net Income
-$143M +1.4% ▲
EPS (Diluted)
$-1.21 +1.6% ▲
EBITDA
-$24M -5.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024
Revenue$215M$245M$305M$343M
YoY Growth+0.0%+13.9%+24.3%+12.4%
Cost of Revenue$163M$190M$266M$295M
Gross Profit$53M$55M$39M$48M
Gross Margin24.4%22.4%12.7%13.9%
R&D Expenses$4M$4M$3M$3M
SG&A Expenses$103M$55M$56M$68M
Operating Expenses$132M$58M$61M$73M
Operating Income-$80M-$4M-$22M-$26M
Operating Margin-37.0%-1.5%-7.3%-7.5%
Interest Expense$16M$16M$14M$13M
Income Before Tax-$96M-$20M-$37M-$37M
Tax Expense$0$0$0$0
Net Income-$188M-$126M-$145M-$143M
Net Margin-87.5%-51.2%-47.7%-41.9%
EPS (Diluted)$-1.59$-1.06$-1.23$-1.21
EBITDA-$59M-$4M-$23M-$24M
Shares Outstanding118M118M118M118M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms